- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy: A Challenge of Breast Cancer Treatment
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 12, Pages 1822
Publisher
MDPI AG
Online
2019-11-21
DOI
10.3390/cancers11121822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes
- (2019) Zhigang Wang et al. Scientific Reports
- Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
- (2019) Fei Peng et al. Nature Nanotechnology
- Peptide vaccines in early breast cancer
- (2019) Carmen Criscitiello et al. BREAST
- Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor
- (2019) Kamal Ahmed et al. CANCER LETTERS
- Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
- (2019) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells
- (2019) Chen-Jei Tai et al. Scientific Reports
- Mutation-Derived Neoantigens for Cancer Immunotherapy
- (2019) John C. Castle et al. Frontiers in Immunology
- Nanotechnology: An Emerging Therapeutic Option for Breast Cancer
- (2018) Zulfia Hussain et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Regulation of Clusterin Gene Expression
- (2018) Marilina Garcia-Aranda et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Tumour growth and immune evasion as targets for a new strategy in advanced cancer
- (2018) Andrea Nicolini et al. ENDOCRINE-RELATED CANCER
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- The Role of the Estrogen Pathway in the Tumor Microenvironment
- (2018) Natalie Rothenberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nivolumab monotherapy or in combination with ipilimumab for metastatic melanoma
- (2018) Amr Menshawy et al. MELANOMA RESEARCH
- Molecular Subtypes and Local-Regional Control of Breast Cancer
- (2018) Simona Maria Fragomeni et al. Surgical Oncology Clinics of North America
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Oncolytic Virotherapy for Breast Cancer Treatment
- (2018) Samia M. O’Bryan et al. CURRENT GENE THERAPY
- Sex Hormones Determine Immune Response
- (2018) Veena Taneja Frontiers in Immunology
- The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
- (2018) Ibrahim Eissa et al. Cancers
- Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer
- (2018) Margaret L Axelrod et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials
- (2018) Zhihang Tao et al. CLINICAL DRUG INVESTIGATION
- Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
- (2018) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
- (2018) Chunmei Fu et al. Frontiers in Immunology
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Protein Kinase Targets in Breast Cancer
- (2017) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)
- (2017) Rose Liu et al. MEDICAL JOURNAL OF AUSTRALIA
- Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
- (2017) Neelima Vidula et al. Oncotarget
- Gene expression profiling of calcifications in breast cancer
- (2017) Sung Ui Shin et al. Scientific Reports
- Breast Cancer Neoantigens Can Induce CD8 + T-Cell Responses and Antitumor Immunity
- (2017) Xiuli Zhang et al. Cancer Immunology Research
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
- (2016) T. Tellez et al. CURRENT MEDICINAL CHEMISTRY
- Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling
- (2016) Hee Jin Lee et al. Oncotarget
- Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
- (2016) A. Forero et al. Cancer Immunology Research
- The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases
- (2016) Deena Khan et al. Frontiers in Immunology
- The Spectrum of Genetic Mutations in Breast Cancer
- (2015) Asfandyar Sheikh et al. Asian Pacific Journal of Cancer Prevention
- The role of CD95 and CD95 ligand in cancer
- (2015) M E Peter et al. CELL DEATH AND DIFFERENTIATION
- Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population
- (2015) Lea Rossi et al. PLoS One
- Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
- (2015) Bharat K. R. Chaganty et al. OncoImmunology
- Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis
- (2014) Zheng-Xu Wang et al. CYTOTHERAPY
- Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines
- (2014) Elham Mohit et al. Expert Review of Clinical Immunology
- The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
- (2014) Arindam Paul Frontiers in Bioscience-Landmark
- Local tumour hyperthermia as immunotherapy for metastatic cancer
- (2014) Seiko Toraya-Brown et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells
- (2014) Ahmed A. Mostafa et al. PLoS One
- High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
- (2014) Zhong-Yu Yuan et al. OncoTargets and Therapy
- Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer
- (2013) Parvin F Peddi et al. Future Oncology
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- Mechanisms of Trastuzumab Resistance in Breast Cancer
- (2012) Sara Tolaney et al. Anti-Cancer Agents in Medicinal Chemistry
- A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
- (2012) Nancy U. Lin et al. BREAST CANCER RESEARCH AND TREATMENT
- Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Javier Cortés et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammatory HER2-positive breast cancer
- (2012) Luc Y Dirix et al. LANCET ONCOLOGY
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Tumor associated regulatory dendritic cells
- (2012) Yang Ma et al. SEMINARS IN CANCER BIOLOGY
- Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression
- (2012) Masayuki Inoue et al. OncoImmunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Two signal models in innate immunity
- (2011) Mary F. Fontana et al. IMMUNOLOGICAL REVIEWS
- Triple-Negative Breast Cancer
- (2010) Shaheenah Dawood DRUGS
- Hyperthermia for locally advanced breast cancer
- (2010) Timothy M. Zagar et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
- (2010) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now